media – Page 652 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

FDA approves Teva’s Austedo for tardive dyskinesia

Teva’s Austedo is now the first and only therapy approved in the US to treat both tardive dyskinesia and chorea associated with Huntington’s disease.
- Source: news.open-medical
- 672
- September 1, 2017
chorea FDA New Approvals tardive dyskinesia Teva
Nemaura develops medical grade diabetes management app

Nemaura Medical Inc. (NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless adhesive skin-patch for adjunctive use by diabetics as a non-invasive and needle-free continuous glucose monitoring (CGM) system announced today that it has completed development of a medical grade app prepared and verified in accordance with ISO13485 quality systems and the appropriate medical devices directives, and designed to be used with the sugarBEAT® device or with glucose meters and strips to display glucose levels on users android mobile devices.
- Source: Drugdeliverybusiness
- 673
- September 1, 2017
diabetes glucose Nemaura Medical Researches
Why do you always lose clients?

The vexing problem of how to increase the loyalty of clients has always been troublesome to people specializing in foreign trade. Salesmen often find that their clients may say goodbye to them and end their business relationship, simply to start a new one and on other occasions, their clients disappear without any notice. In order to mitigate issues such as these, we should know what causes this behavior and how to remedy the problem.
- Source: Ddu
- 2,214
- September 1, 2017
client Ddu College quality
China’s Import and Export of Diagnostic Equipment Report

With economic development and the ongoing medical reform, people are becoming more and more concerned about their health care and the diagnostic equipment market in China is growing at a compound annual rate of about 10%.
- Source: Ddu
- 918
- August 31, 2017
diagnostic Market Reports
MicroPort Orthopedics launches new acetabular cup system

MicroPort Orthopedics has launched its new Procotyl Prime Acetabular Cup System, following 510(k) clearance from the US Food and Drug Administration in June.
- Source: medicaldevice-network
- 480
- August 31, 2017
acetabular cup system Company Insight MicroPort Orthopedics
This Drug Has Significant Implications for Heart Disease

An anti-inflammatory drug has significantly lowered the risk of recurrent heart attacks, strokes and cardiovascular death, all without reducing cholesterol, according to research recently published in the New England Journal of Medicine and shared at a meeting of the European Society of Cardiology.
- Source: newsjs
- 587
- August 31, 2017
anti-inflammatory cardiovascular Clinical Trials heart attacks stroke
FDA Approves New Antibiotics to Treat Kidney Infections by “Superbugs”

Adult peoples with complicated urinary tract infections (cUTI) like pyelonephritis– a type of kidney infection caused by specific bacteria- suffer from many inconvenient problems like painful urination. It may lead to serious life threatening conditions including permanent kidney damage.
- Source: medgenera
- 749
- August 31, 2017
cUTI kidney New Approvals pyelonephritis
NIH develops robotic exoskeleton to treat crouch gait in children

A robotic exoskeleton for the treatment of crouch (or flexed-knee) gait in children with cerebral palsy has been developed by US researchers from the Rehabilitation Medicine department of the NIH Clinical Centre.
- Source: medicaldevice-network
- 669
- August 30, 2017
cerebral Crouch gait Researches
EUSA bags EU approval for kidney cancer drug

The European Commission has licensed EUSA Pharma’s Fotivda for the management of adult patients with advanced kidney cancer across the European Union as well as Norway and Iceland.
- Source: open-medical
- 585
- August 30, 2017
cancer inhibitor kidney New Approvals
MedGenome raises $30m for biomarker discovery program

MedGenomeGenomics research and diagnostics company MedGenome said today that it closed a $30 million Series C round led by Sequoia India and Sofina. Zodius Capital, the co-founder & former CEO of Infosys, Kris Gopalakrishnan, and former Cognizant CEO Lakshmi Narayanan also participated in the round.
- Source: drugdeliverybusiness
- 623
- August 30, 2017
genetic immunotherapy Market Views Series

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.